How to face the aging world – lessons from dementia research
暂无分享,去创建一个
M. di Luca | B. Zavan | G. Tricarico | D. Mitrečić | M. Kujundžić Tiljak | Jasmina Isaković | D. Petrović | Paula Stančin
[1] K. Blennow,et al. Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration , 2020, Neurobiology of Disease.
[2] Q. Tu,et al. miR-340 reduces accumulation of amyloid-β through targeting BACE1 (β-site amyloid precursor protein cleaving enzyme 1) in Alzheimer' s disease. , 2020, Current neurovascular research.
[3] Yunjia Chen,et al. β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade , 2020, Science Translational Medicine.
[4] V. Libri,et al. Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations , 2020, JAMA neurology.
[5] John P. Williams,et al. Ozone Inhibits APP/Aβ Production and Improves Cognition in an APP/PS1 Transgenic Mouse Model , 2019, Neuroscience.
[6] M. Phillips. Fasting as a Therapy in Neurological Disease , 2019, Nutrients.
[7] J. Wiltfang,et al. CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.
[8] Sudha Seshadri,et al. Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis , 2019, BMJ.
[9] D. Mitrečić,et al. Molecular mechanisms of microglia- and astrocyte-driven neurorestoration triggered by application of electromagnetic fields , 2019, Croatian medical journal.
[10] R. Pochet,et al. A call for unification: how to defragment the human brain, medical professions, and national strategies? , 2019, Croatian medical journal.
[11] J. Trojanowski,et al. Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology , 2019, Molecular Neurodegeneration.
[12] A. Fagan,et al. Reduced non–rapid eye movement sleep is associated with tau pathology in early Alzheimer’s disease , 2019, Science Translational Medicine.
[13] J. Boeke,et al. LINE-1 derepression in senescent cells triggers interferon and inflammaging , 2018, Nature.
[14] D. Chaudhury,et al. Modeling of inhomogeneous electromagnetic fields in the nervous system: a novel paradigm in understanding cell interactions, disease etiology and therapy , 2018, Scientific Reports.
[15] K. Blennow,et al. Biomarkers for Alzheimer's disease: current status and prospects for the future , 2018, Journal of internal medicine.
[16] B. Kennedy,et al. Development, Application, and Results from a Precision-medicine Platform that Personalizes Multi-modal Treatment Plans for Mild Alzheimer’s Disease and At-risk Individuals , 2018, Current aging science.
[17] Laila E. Amin. Biological assessment of ozone therapy on experimental oral candidiasis in immunosuppressed rats , 2018, Biochemistry and biophysics reports.
[18] L. Fassina,et al. Low-Frequency Pulsed Electromagnetic Field Is Able to Modulate miRNAs in an Experimental Cell Model of Alzheimer's Disease , 2017, Journal of healthcare engineering.
[19] D. Kapogiannis,et al. Insulin resistance in Alzheimer's disease , 2017, Translational research : the journal of laboratory and clinical medicine.
[20] D. Barrett,et al. Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice , 2017, Brain : a journal of neurology.
[21] T. Oosterkamp,et al. Human-brain ferritin studied by muon spin rotation: a pilot study , 2017, Journal of physics. Condensed matter : an Institute of Physics journal.
[22] H. Aldskogius,et al. Murine neural crest stem cells and embryonic stem cell‐derived neuron precursors survive and differentiate after transplantation in a model of dorsal root avulsion , 2017, Journal of tissue engineering and regenerative medicine.
[23] S. Gajović,et al. Neural stem cells from mouse strain Thy1 YFP-16 are a valuable tool to monitor and evaluate neuronal differentiation and morphology , 2016, Neuroscience Letters.
[24] Dale E. Bredesen,et al. Reversal of cognitive decline in Alzheimer's disease , 2016, Aging.
[25] T. Montine,et al. Precision Medicine: Clarity for the Complexity of Dementia. , 2016, The American journal of pathology.
[26] D. Bredesen. Inhalational Alzheimer's disease: an unrecognized—and treatable—epidemic , 2016, Aging.
[27] D. Selkoe,et al. C-Terminally Truncated Forms of Tau, But Not Full-Length Tau or Its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death , 2015, The Journal of Neuroscience.
[28] Lars Bäckman,et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.
[29] Hyung-Do Choi,et al. 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer’s Disease Mice , 2015, Current Alzheimer research.
[30] S. Kourembanas. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. , 2015, Annual review of physiology.
[31] S. Rossi,et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) , 2014, Clinical Neurophysiology.
[32] Dale E. Bredesen,et al. Reversal of cognitive decline: A novel therapeutic program , 2014, Aging.
[33] S. Golaszewski,et al. Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease , 2014, Acta neurologica Scandinavica.
[34] K. Zilles,et al. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia , 2014, Molecular Psychiatry.
[35] N. Tyagi,et al. Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics , 2014, Molecular Neurobiology.
[36] G. Müller,et al. Microvesicles/exosomes as potential novel biomarkers of metabolic diseases , 2012, Diabetes, metabolic syndrome and obesity : targets and therapy.
[37] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[38] M. Nitsche,et al. Physiological Basis of Transcranial Direct Current Stimulation , 2011, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[39] B. Winblad,et al. Homocysteine and holotranscobalamin and the risk of Alzheimer disease , 2010, Neurology.
[40] R. Wennberg,et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease , 2010, Annals of neurology.
[41] Graça Raposo,et al. Exosomes--vesicular carriers for intercellular communication. , 2009, Current opinion in cell biology.
[42] K. Blennow,et al. The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients. , 2008, Clinical chemistry.
[43] F. LaFerla,et al. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid , 2007, Neuroscience & Biobehavioral Reviews.
[44] G. Raposo,et al. Exosomes: a common pathway for a specialized function. , 2006, Journal of biochemistry.
[45] Yoshikazu Ugawa,et al. Long‐term effect of motor cortical repetitive transcranial magnetic stimulation induces , 2004 .
[46] M. Nitsche,et al. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. , 2002, Brain : a journal of neurology.
[47] N. Mokhov,et al. Muons versus hadrons for radiotherapy , 1999, Proceedings of the 1999 Particle Accelerator Conference (Cat. No.99CH36366).
[48] Hae-June Lee,et al. MHz Electromagnetic Fields Ameliorate A β Pathology in Alzheimer ’ s Disease Mice , 2015 .
[49] Q. Mu,et al. Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer's Disease: A Meta-Analysis. , 2015, Journal of Alzheimer's disease : JAD.
[50] D. Bohl,et al. Genetically modified stem cells for the treatment of neurological diseases. , 2012, Frontiers in bioscience.
[51] Jun Tan,et al. Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice. , 2010, Journal of Alzheimer's disease : JAD.
[52] G. Parmiani,et al. Tumour-released exosomes and their implications in cancer immunity , 2008, Cell Death and Differentiation.
[53] V. Bocci. OZONE: A new medical drug , 2005 .